dots health software glp-1 Ro launches supply tracker to help patients navigate shortages GLP-1 Optimization Program | DexaFit

Patients should only use GLP-1 medications prescribed by licensed healthcare providers and obtained through legitimate pharmacies, ensuring product authenticity and appropriate medical supervision

This constraint has hindered structureactivity relationship studies and rational pharmacologic development

That said, there are some GLP-1 superlatives to keep in mind

In a recent NOTW, I shared what I believed to be the three reasons behind the weakness (in relevance order): The narrative around oral GLP-1s Schotts weak FY 2026 guidance (shared early in December) Stevanatos low float (80% or so remains in the hands of the Stevanato family) #3 is what it is and we cant do much about it